United States · 
Who invested in Mytide Therapeutics?
Mytide Therapeutics's investors include National Science Foundation and Creative Destruction Lab.
United States · Series A startup
Who invested in Mytide Therapeutics
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $7.0MMar 2022
- Investors
- 2
The rounds
- Mar 2022Series A$7.0M
Source recordedSEC filing: $6.6M sold, first sale Dec 2021
Founders and team
From the SEC filings it signed: 2 on the team.
- Dale ThomasMr. Thomas is the President of the Issuer.i
- Jason NorrisMr. Norris is the Treasurer and Secretary of the Issuer.i
On the board, as filediErrik Anderson
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Mytide Therapeutics
How much has Mytide Therapeutics raised?
Mytide Therapeutics has raised $7.0M across 1 round since 2022.
When did Mytide Therapeutics last raise?
Mytide Therapeutics's most recent round was a Series A of $7.0M in Mar 2022.
What was Mytide Therapeutics's biggest round?
Its most recent round, $7.0M in Mar 2022, is also its largest on record.
Who backed Mytide Therapeutics first?
Mytide Therapeutics's first round on record, in Mar 2022, was backed by National Science Foundation and Creative Destruction Lab.
What stage is Mytide Therapeutics at?
Mytide Therapeutics's latest named round is a Series A, in Mar 2022.
Where is Mytide Therapeutics based?
Mytide Therapeutics is based in the United States.
Companies like Mytide Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.